Medical experts welcomed the news that the Pfizer-BioNTech Covid vaccine could be authorized by the Food and Drug Administration for use in adolescents ages 12 to 15 by early next week, a major step forward in the U.S. vaccination campaign.
Vaccinating children is key to raising the level of immunity in the population, experts say, and to bringing down the numbers of hospitalizations and deaths. And it could put school administrators, teachers and parents at ease if millions of adolescent students soon become eligible for vaccinations before the next academic year begins in September.
Click here to view original web page at www.nytimes.com
Keidy Ventura, 17, received a dose of the Pfizer coronavirus vaccine in West New York, N.J., last month.Credit...Seth Wenig/Associated Press Medical experts welcomed the news that the Pfizer-BioNTech Covid vaccine could be authorized by the Food and Drug Administration for use in adolescents ages 12 to 15 by early [...]